Amendment to Solicitation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

242-NETWORK CONTRACT OFFICE 02 (36C242)

Contract Value

Not provided

Codes & Classification
Solicitation Number

242

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

New York, UNITED STATES

SourceSAM
Documents2
The Department of Veterans Affairs, through its Network Contract Office 02 (36C242), has issued an amendment to Solicitation 36C24226Q0827, seeking qualified vendors for a procurement activity related to in-vitro diagnostic substance manufacturing. This solicitation, classified under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing, 2022), is intended to support the agency’s ongoing commitment to providing high-quality diagnostic solutions within its New York operations. The scope of this procurement encompasses the supply or manufacturing of in-vitro diagnostic substances, as indicated by the Product Service Code 6640. The intended outcome is to ensure reliable access to diagnostic materials that are essential for the medical and laboratory services provided to veterans. The place of performance is specified as New York, United States, underscoring the regional focus of this requirement. There are no set-aside requirements for this solicitation, meaning it is open to all qualified vendors regardless of business size or socioeconomic status. Contractors should note that this is a federal procurement managed by the Department of Veterans Affairs, with oversight from the Network Contract Office 02. The contracting entity is an office-level organization, and all communications regarding this opportunity should be directed to the primary contact, Aleta Jennette, at [email protected]. The solicitation remains active, with a post date of April 9, 2026, and a response deadline of October 9, 2026. Interested parties are encouraged to review the amendment and associated attachments available via the official SAM.gov opportunity page (https://sam.gov/opp/a9cebfa5d0544850bbf0068f348c72ff/view) for further details and submission instructions. Contractors evaluating this opportunity should ensure their capabilities align with the manufacturing and supply of in-vitro diagnostic substances, as well as compliance with federal procurement standards. The requirements and objectives outlined in the solicitation are expected to remain consistent throughout the contract lifecycle, focusing on the delivery of reliable diagnostic products to support veteran healthcare services in New York.